SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Enveric Biosciences, Inc. – ‘S-4/A’ on 9/16/20 – ‘EXCEL’

On:  Wednesday, 9/16/20, at 6:05pm ET   ·   As of:  9/17/20   ·   Accession #:  1493152-20-17916   ·   File #:  333-238742

Previous ‘S-4’:  ‘S-4/A’ on 8/12/20   ·   Next:  ‘S-4/A’ on 10/22/20   ·   Latest:  ‘S-4/A’ on 8/4/21   ·   21 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/17/20  AMERI Holdings, Inc.              S-4/A       9/16/20  118:18M                                    M2 Compliance LLC/FA

Pre-Effective Amendment to Registration Statement – Securities for a Merger   —   Form S-4   —   SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4/A       Pre-Effective Amendment to Registration Statement   HTML   5.37M 
                - Securities for a Merger                                        
 2: EX-23.4     Consent of Expert or Counsel                        HTML     30K 
 3: EX-23.5     Consent of Expert or Counsel                        HTML     30K 
10: R1          Document and Entity Information                     HTML     45K 
11: R2          Condensed Consolidated Balance Sheets               HTML    143K 
12: R3          Condensed Consolidated Balance Sheets               HTML     48K 
                (Parenthetical)                                                  
13: R4          Condensed Consolidated Statements of Operations     HTML    144K 
                and Comprehensive Income (Loss)                                  
14: R5          Condensed Consolidated Statement of Changes in      HTML    115K 
                Stockholders' Equity                                             
15: R6          Condensed Consolidated Statements of Cash Flows     HTML    114K 
16: R7          Description of Business                             HTML     44K 
17: R8          Summary of Significant Accounting Policies          HTML     92K 
18: R9          Basis of Presentation                               HTML     50K 
19: R10         Equity Transactions                                 HTML     51K 
20: R11         Business Combinations                               HTML     89K 
21: R12         Revenue Recognition                                 HTML     57K 
22: R13         Intangible Assets                                   HTML     46K 
23: R14         Goodwill                                            HTML     38K 
24: R15         Share-Based Compensation                            HTML     35K 
25: R16         Equity Compensation Plans                           HTML     72K 
26: R17         Earnings (Loss) Per Share                           HTML     54K 
27: R18         Debt                                                HTML     43K 
28: R19         Accrued Expenses and Other Current Liabilities      HTML     36K 
29: R20         Incentive Plan Items                                HTML     32K 
30: R21         Employee Benefit Plan                               HTML     32K 
31: R22         Income Taxes                                        HTML     45K 
32: R23         Bank Debt                                           HTML     35K 
33: R24         Convertible Notes                                   HTML     36K 
34: R25         Leases                                              HTML     63K 
35: R26         Fair Value Measurement                              HTML     54K 
36: R27         Warrants Outstanding                                HTML     47K 
37: R28         Preferred Stock                                     HTML     33K 
38: R29         Secured Note                                        HTML     33K 
39: R30         Loan From Paycheck Protection Program (Ppp)         HTML     33K 
40: R31         Loan From U.S. Small Business Administration        HTML     33K 
                (Eidl)                                                           
41: R32         Exchange of Convertible Note and Promissory Notes   HTML     33K 
42: R33         Registered Direct Offering                          HTML     34K 
43: R34         Material Agreements                                 HTML     36K 
44: R35         Revision of Prior Year Financial Statements         HTML    104K 
45: R36         Subsequent Events                                   HTML     62K 
46: R37         Summary of Significant Accounting Policies          HTML    147K 
                (Policies)                                                       
47: R38         Summary of Significant Accounting Policies          HTML     43K 
                (Tables)                                                         
48: R39         Business Combinations (Tables)                      HTML     63K 
49: R40         Intangible Assets (Tables)                          HTML     47K 
50: R41         Goodwill (Tables)                                   HTML     36K 
51: R42         Equity Compensation Plans (Tables)                  HTML     71K 
52: R43         Revenue Recognition (Tables)                        HTML     43K 
53: R44         Earnings (Loss) Per Share (Tables)                  HTML     50K 
54: R45         Debt (Tables)                                       HTML     36K 
55: R46         Accrued Expenses and Other Current Liabilities      HTML     36K 
                (Tables)                                                         
56: R47         Income Taxes (Tables)                               HTML     39K 
57: R48         Leases (Tables)                                     HTML     60K 
58: R49         Warrants Outstanding (Tables)                       HTML     47K 
59: R50         Fair Value Measurement (Tables)                     HTML     49K 
60: R51         Revision of Prior Year Financial Statements         HTML    101K 
                (Tables)                                                         
61: R52         Description of Business (Details Narrative)         HTML     57K 
62: R53         Description of Business (Details Narrative) (10-K)  HTML     57K 
63: R54         Summary of Significant Accounting Policies          HTML     44K 
                (Details Narrative) (10-K)                                       
64: R55         Summary of Significant Accounting Policies -        HTML     51K 
                Schedule of Disaggregation of Revenue (Details)                  
                (10-K)                                                           
65: R56         Equity Transactions (Details Narrative) (10-K)      HTML    121K 
66: R57         Business Combinations (Details Narrative)           HTML     72K 
67: R58         Business Combinations (Details Narrative) (10-K)    HTML    119K 
68: R59         Business Combinations - Summary of Foregoing        HTML     85K 
                Acquisitions (Details)                                           
69: R60         Revenue Recognition (Details Narrative)             HTML     42K 
70: R61         Revenue Recognition - Schedule of Disaggregate      HTML     50K 
                Revenue (Details)                                                
71: R62         Intangible Assets (Details Narrative)               HTML     33K 
72: R63         Intangible Assets (Details Narrative) (10-K)        HTML     38K 
73: R64         Intangible Assets - Schedule of Components of       HTML     41K 
                Intangible Assets (Details) (10-K)                               
74: R65         Intangible Assets - Schedule of Future              HTML     40K 
                Amortization of Intangible Assets (Details) (10-K)               
75: R66         Goodwill (Details Narrative)                        HTML     33K 
76: R67         Goodwill (Details Narrative) (10-K)                 HTML     33K 
77: R68         Goodwill - Schedule of Goodwill (Details) (10-K)    HTML     37K 
78: R69         Share-Based Compensation (Details Narrative)        HTML     38K 
                (10-K)                                                           
79: R70         Equity Compensation Plans (Details Narrative)       HTML     40K 
                (10-K)                                                           
80: R71         Equity Compensation Plans - Schedule of Option      HTML     73K 
                Activity (Details) (10-K)                                        
81: R72         Earnings (Loss) Per Share - Schedule of Earnings    HTML     65K 
                Per Share Basic and Diluted (Details)                            
82: R73         Earnings / (loss) Per Share - Schedule of Earnings  HTML     67K 
                Per Share Basic and Diluted (Details) (10-K)                     
83: R74         Debt (Details Narrative) (10-K)                     HTML     77K 
84: R75         Debt - Schedule of Short Term Debt (Details)        HTML     38K 
                (10-K)                                                           
85: R76         Accrued Expenses and Other Current Liabilities -    HTML     45K 
                Schedule of Accrued Expenses and Other Liabilities               
                (Details) (10-K)                                                 
86: R77         Incentive Plan Items (Details Narrative)            HTML     32K 
87: R78         Employee Benefit Plan (Details Narrative) (10-K)    HTML     38K 
88: R79         Income Taxes (Details Narrative) (10-K)             HTML     38K 
89: R80         Income Taxes - Schedule of Provision for Income     HTML     54K 
                Tax (Details) (10-K)                                             
90: R81         Bank Debt (Details Narrative)                       HTML     46K 
91: R82         Convertible Notes (Details Narrative)               HTML     67K 
92: R83         Leases (Details Narrative)                          HTML     35K 
93: R84         Leases - Schedule of Components of Lease Expense    HTML     36K 
                (Details)                                                        
94: R85         Leases - Schedule of Supplemental Balance Sheet     HTML     39K 
                Information Related to Leases (Details)                          
95: R86         Leases - Schedule of Supplemental Cash Flow and     HTML     40K 
                Other Information Related to Leases (Details)                    
96: R87         Leases - Schedule of Maturity Payments of           HTML     50K 
                Operating Leases (Details)                                       
97: R88         Leases (Details Narrative) (10-K)                   HTML     35K 
98: R89         Leases - Schedule of Components of Lease Expense    HTML     36K 
                (Details) (10-K)                                                 
99: R90         Leases - Schedule of Supplemental Balance Sheet     HTML     39K 
                Information Related to Leases (Details) (10-K)                   
100: R91         Leases - Schedule of Supplemental Cash Flow and     HTML     40K  
                Other Information Related to Leases (Details)                    
                (10-K)                                                           
101: R92         Leases - Schedule of Maturity Payments of           HTML     46K  
                Operating Leases (Details) (10-K)                                
102: R93         Fair Value Measurement - Schedule of Financial      HTML     41K  
                Assets Measured at Fair Value (Details) (10-K)                   
103: R94         Fair Value Measurement - Schedule of Fair Value     HTML     40K  
                Change in Levels (Details) (10-K)                                
104: R95         Warrants Outstanding - Schedule of Warrant          HTML     49K  
                Outstanding (Details)                                            
105: R96         Warrants - Schedule of Warrants Activity (Details)  HTML     54K  
                (10-K)                                                           
106: R97         Preferred Stock (Details Narrative)                 HTML     42K  
107: R98         Secured Note (Details Narrative)                    HTML     36K  
108: R99         Loan From Paycheck Protection Program (Ppp)         HTML     41K  
                (Details Narrative)                                              
109: R100        Loan From U.S. Small Business Administration        HTML     42K  
                (Eidl) (Details Narrative)                                       
110: R101        Exchange of Convertible Note and Promissory Notes   HTML     40K  
                (Details Narrative)                                              
111: R102        Registered Direct Offering (Details Narrative)      HTML     50K  
112: R103        Revision of Prior Year Financial Statements -       HTML    142K  
                Schedule of Consolidated Financial Statements                    
                Previously (Details)                                             
113: R104        Revision of Prior Year Financial Statements -       HTML    142K  
                Schedule of Consolidated Financial Statements                    
                Previously (Details) (10-K)                                      
114: R105        Subsequent Events (Details Narrative)               HTML     50K  
115: R106        Subsequent Events (Details Narrative) (10-K)        HTML     69K  
117: XML         IDEA XML File -- Filing Summary                      XML    226K  
116: EXCEL       IDEA Workbook of Financial Reports                  XLSX    166K  
 4: EX-101.INS  XBRL Instance -- amrh-20200630                       XML   2.38M 
 6: EX-101.CAL  XBRL Calculations -- amrh-20200630_cal               XML    246K 
 7: EX-101.DEF  XBRL Definitions -- amrh-20200630_def                XML    786K 
 8: EX-101.LAB  XBRL Labels -- amrh-20200630_lab                     XML   1.26M 
 9: EX-101.PRE  XBRL Presentations -- amrh-20200630_pre              XML   1.13M 
 5: EX-101.SCH  XBRL Schema -- amrh-20200630                         XSD    264K 
118: ZIP         XBRL Zipped Folder -- 0001493152-20-017916-xbrl      Zip    220K  


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/20  Enveric Biosciences, Inc.         S-4/A                113:17M                                    M2 Compliance LLC/FA
 5/28/20  Enveric Biosciences, Inc.         S-4         5/27/20   98:16M                                    M2 Compliance LLC/FA
 5/06/20  Enveric Biosciences, Inc.         8-K:1,2,3,9 5/06/20    6:372K                                   Broadridge Fin’l So… Inc
 3/04/20  Enveric Biosciences, Inc.         8-K:1,2,9   2/27/20    3:91K                                    Broadridge Fin’l So… Inc
 1/13/20  Enveric Biosciences, Inc.         8-K:1,3,8,9 1/10/20    9:2M                                     Broadridge Fin’l So… Inc
11/25/19  Enveric Biosciences, Inc.         8-K:1,2,9  11/25/19    3:297K                                   Broadridge Fin’l So… Inc
 8/14/19  Enveric Biosciences, Inc.         S-3                    5:1.1M                                   Broadridge Fin’l So… Inc
 3/26/19  Enveric Biosciences, Inc.         10-K       12/31/18   73:7.1M                                   Broadridge Fin’l So… Inc
 1/25/19  Enveric Biosciences, Inc.         8-K:1,2,9   1/23/19    6:465K                                   Broadridge Fin’l So… Inc
12/14/18  Enveric Biosciences, Inc.         8-K:3,5,9  12/10/18    3:97K                                    Broadridge Fin’l So… Inc
10/17/18  Enveric Biosciences, Inc.         8-K:1,5,9  10/16/18    3:78K                                    Olshan Frome Wolosky LLP
 8/17/18  Enveric Biosciences, Inc.         8-K:1,3,5,8 8/16/18    5:254K                                   Olshan Frome Wolosky LLP
 7/30/18  Enveric Biosciences, Inc.         8-K:1,3,8,9 7/25/18    6:613K                                   Olshan Frome Wolosky LLP
 6/26/18  Enveric Biosciences, Inc.         8-K:1,9     6/22/18    3:282K                                   Olshan Frome Wolosky LLP
 3/02/18  Enveric Biosciences, Inc.         8-K:1,9     2/28/18    2:37K                                    Olshan Frome Wolosky LLP
 3/08/17  Enveric Biosciences, Inc.         8-K:1,3,9   3/02/17    4:169K                                   Olshan Frome Wolosky LLP
 1/04/17  Enveric Biosciences, Inc.         8-K:1,3,5,912/30/16    3:146K                                   Olshan Frome Wolosky LLP
 6/23/16  Enveric Biosciences, Inc.         8-K:5,9     6/21/16    3:254K                                   Olshan Frome Wolosky LLP
12/17/15  Enveric Biosciences, Inc.         S-8        12/17/15    4:480K                                   Olshan Frome Wolosky LLP
11/23/15  Enveric Biosciences, Inc.         10-Q        9/30/15   32:1.3M                                   Edgar.Tech Fili… Svcs/FA
 6/01/15  Enveric Biosciences, Inc.         8-K:1,2,3,4 5/26/15   15:1.9M                                   Olshan Frome Wolosky LLP
Top
Filing Submission 0001493152-20-017916   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 4:15:33.2am ET